Evaluation of Immunostimulatory Potential of Branded and US-Generic Enoxaparins in an In Vitro Human Immune System Model

Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity

(2014) Sven Brandt et al.   THROMBOSIS AND HAEMOSTASIS

Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: A review of pharmacologic and clinical differences and applications in patients with cancer

(2013) Jeanine M. Walenga et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Scientific considerations in the review and approval of generic enoxaparin in the United States

(2013) Sau Lee et al.   NATURE BIOTECHNOLOGY

Comparative Studies on Branded Enoxaparin and a US Generic Version of Enoxaparin

(2012) Jeanine M. Walenga et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Binding of heparin-dependent antibodies to PF4 modified by enoxaparin oligosaccharides: evaluation by surface plasmon resonance and serotonin release assay

(2012) D. LEROUX et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Heparin modifies the immunogenicity of positively charged proteins

(2010) S. L. Chudasama et al.   BLOOD

Assessing the immunopotency of Toll-like receptor agonists in anin vitrotissue-engineered immunological model

(2010) Yifan Ma et al.   IMMUNOLOGY

Optimization of a murine immunization model for study of PF4/heparin antibodies

(2009) S. SUVARNA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings

(2008) A. Greinacher et al.   THROMBOSIS RESEARCH